Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Avesta Ketamine and Wellness is Opening a Second Location in McLean Virginia November 2020

Avesta Ketamine and Wellness is excited to announce the opening of their second location in McLean Virginia November 2020. Avesta Ketamine and Wellness is a provider of IV Ketamine Infusions for the treatment of depression, anxiety, PTSD, migraines, fibromyalgia, and chronic pain. They are also a provider of IV Vitamin Infusions for health and wellness.


News provided by

Avesta Ketamine and Wellness

Oct 16, 2020, 16:00 ET

Share this article

Share toX

Share this article

Share toX

Dr. Ladan Eshkevari
Dr. Ladan Eshkevari

MCLEAN, Va., Oct. 16, 2020 /PRNewswire-PRWeb/ -- Avesta Ketamine and Wellness is excited to announce the opening of their second location in McLean Virginia November 2020. Avesta Ketamine and Wellness is a provider of IV Ketamine Infusions for the treatment of depression, anxiety, PTSD, migraines, fibromyalgia, and chronic pain. They are also a provider of IV Vitamin Infusions for health and wellness.

About Dr. Ladan Eshkevari, PhD, CRNA, FAAN
Dr. Ladan Eshkevari is the lead clinician at Avesta Ketamine and Wellness and Program Director and Associate Professor in the Doctor of Nurse Anesthesia Practice program at Georgetown University. An award-winning provider, Dr. Eshkevari is an expert in the areas of anesthesia, pain management, and alternative medicine, specializing in central and peripheral mechanisms of pain and stress responses. Dr. Eshkevari has been published in numerous journals, including Experimental Biology and Medicine, and Endocrinology. Her research has stimulated international interest in her work, which has been highlighted in numerous popular magazines such as National Geographic, Time Magazine and on NPR Boston. She was recently inducted as a Fellow in the American Academy of Nursing, the highest honor bestowed on nurses both nationally, and internationally. Known for her compassionate bedside manner, high-level of professionalism, and individualized approach, Dr. Eshkevari is a pioneer in her field.

Many patients who are struggling with treatment resistant depression, PTSD or anxiety find real relief and new hope with ketamine treatments. In today’s anxiety-stricken environment is more important than ever for people to be able to get the help they need--and get real relief.

Post this

About Ketamine Infusions For Depression, Anxiety, PTSD
A faithful advocate, Dr. Eshkevari explains, "You may have heard that Ketamine is available for the treatment of mood disorders such as major depression, PTSD, anxiety as well as chronic pain, but beyond that you may not know much more. Many patients who are struggling with treatment resistant depression, PTSD or anxiety find real relief and new hope with ketamine treatments. In today's anxiety-stricken environment is more important than ever for people to be able to get the help they need--and get real relief. I encourage everyone to get the facts about Ketamine."

Understanding Ketamine
The World Health Organization (WHO) deems, "Ketamine [is] one of the most essential medications due to its therapeutic effects and wide margin of safety." Developed in the 1960s and approved for use in the United States in 1970, Ketamine works by inducing both hypnotic (sleep-inducing) and analgesic (pain-relieving) effects. Ketamine is deemed a complete anesthetic with minimal effects on cardiovascular function, respiratory drive, and airway reflexes. It is used extensively for pediatric and adult treatment in surgery, emergency departments, trauma medicine, and war zones."

How Ketamine Works
Dr. Eshkevari explains, "Ketamine works on several brain areas involved in symptoms of depression, anxiety, suicidal ideation, obsessive compulsive disorder (OCD), post-traumatic stress disorder (PTSD), postpartum depression (PPD), and numerous pain syndromes. It helps with shuttling needed neurotransmitters to where they are depleted, and has been shown to grow new neuronal connections in animal models of depression and anxiety." In fact she says, "In the last decade, there has been mounting evidence that up to 80% of patients suffering from treatment-resistant depression have benefited from Ketamine infusions."

Are Ketamine Infusions Safe?
Ketamine IV infusion treatments for mood disorders and chronic pain are very safe when administered by clinicians like highly trained anesthesia providers with board certifications. Additionally, Ketamine has a strong body of evidence-based research supporting its use. In fact, numerous certified registered nurse anesthetists (CRNAs) have conducted extensive research on stress and impacts on the brain including depression and anxiety and have found ketamine to be highly effective, therapeutic, and non-addictive, which are three of the most critical factors supporting its clinical use for mood disorders and chronic pain.

Who is the ideal candidate for Ketamine Infusions?
Dr. Eshkevari notes, "The ideal candidate is typically a patient that has tried other forms of treatment without success and/or has been diagnosed as treatment resistant. Ketamine can often be the difference in a patient resuming a normal and healthy lifestyle, which usually they had not thought possible because of a history of successive treatment failures. For many, ketamine IV infusion treatments restore hope."

The facts about Ketamine

  • Patients cannot administer IV Ketamine or Esketamine (Spravato) themselves
  • Unlike opioids, Ketamine is physically non-addictive
  • Patients must demonstrate a clinical need
  • IV Ketamine, and Spravato Ketamine are only available at a certified doctor's office or clinic

Their newest McLean office is located at 6861 Elm Street, Suite 3E McLean, Virginia 22101. If you would like to learn more about Avesta Ketamine and Wellness, please visit http://www.avestaketaminewellness.com or call 703-201-7767. Also, follow them on Facebook page @avestaketaminewellness for updates, tips, ideas and more.

References
Thirty-sixth WHO Expert Committee on Drug Dependence agenda item 6.2. Letter from the World Society of Intravenous Anaesthesia to the WHO Expert Committee on Drug Dependence. Geneva, WHO, 2014

Tiger, M., Veldman, E.R., Ekman, C. et al. A randomized placebo-controlled PET study of ketamine´s effect on serotonin1B receptor binding in patients with SSRI-resistant depression. Transl Psychiatry 10, 159 (2020). https://doi.org/10.1038/s41398-020-0844-4

SOURCE Avesta Ketamine and Wellness

Related Links

http://www.avestaketaminewellness.com

Modal title

Avesta Ketamine and Wellness Logo
Avesta Ketamine and Wellness Logo
Avesta Ketamine and Wellness Logo

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.